UK Biobank LIMITED
England
- UEI
- Q834HNV69B21
- CAGE
- U1WS5
- Primary NAICS
- 518210 Computing Infrastructure Providers, Data Processing, Web Hosting, and Related Services
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Tax Exempt)
- SAM.gov registration date
- Physical address
- 1, 2 Spectrum Way, Stockport SK3 0SA, UK
- Website
- ukbiobank.ac.uk
- Employees
- 51-250
- Estimated annual revenue
- $10M-$50M
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Biotechnology
- SIC code
- 87 Engineering & Management Services
- Profiles
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Contract obligations by fiscal year
| Fiscal year | Obligated |
|---|---|
| FY2027 To date | $0 |
| FY2026 | -$733 |
| FY2025 | $75,556 |
| FY2024 | $63,004 |
| FY2023 | $38,388 |
Contract awards
Latest 5 listed here. See the rest on GovTribe.
Similar vendors
About the company
UK Biobank LIMITED is a non-profit organization based in Stockport, United Kingdom, that serves as a critical intermediary for advanced biomedical research by providing large-scale, de-identified medical and genetic datasets. Registered in SAM.gov, the organization maintains a comprehensive biobank containing genetic, lifestyle, and health information from over 500,000 UK participants. These extensive datasets are invaluable resources for scientific researchers seeking to understand complex medical conditions, genetic variations, and population health trends across multiple disciplines.
The organization primarily provides data access services to various federal agencies within the National Institutes of Health (NIH), including the National Cancer Institute, National Institute of Mental Health, National Heart Lung and Blood Institute, National Institute on Aging, National Human Genome Research Institute, National Eye Institute, and National Institute on Alcohol Abuse and Alcoholism. The contract awards, consistently structured as firm fixed-price purchase orders, range from $10,000 to $15,000 and typically cover Tier 2 or Tier 3 data access fees for periods spanning 11 days to 36 months. These contracts enable researchers to access whole exome and genome data linked to electronic health records, facilitating studies on pathogenic variants, age-related diseases, heart/lung/blood disorders, cancer, alcoholism, and mental health research. None of the contracts have set-aside designations, and UK Biobank LIMITED serves as the prime contractor, delivering specialized laboratory and testing services alongside comprehensive dataset access.
Quick answers
Is UK Biobank LIMITED registered in SAM.gov?
Yes. UK Biobank LIMITED's SAM.gov registration is active through February 5, 2027.
What is UK Biobank LIMITED's CAGE code?
UK Biobank LIMITED's CAGE code is U1WS5, and its Unique Entity ID (UEI) is Q834HNV69B21.
How much has UK Biobank LIMITED received in federal contracts?
Federal contracts obligated $75,556 to UK Biobank LIMITED in fiscal year 2025 and $176,216 in fiscal years 2023 through 2027.
What is UK Biobank LIMITED's most recent federal award?
UK Biobank LIMITED's most recent federal contract award is Niaaa: service: ukbb's all individual-level genomic, metabolomic, proteomic, imaging, and linked health-record data… (75N94025P00640), from National Institute of Child Health and Human Development (NIH), on September 23, 2025.
On GovTribe
See UK Biobank LIMITED's full federal record
- Federal contract awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors